-
SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
van der Werf, I., Wojtuszkiewicz, A., Yao, H., Sciarrillo, R., Meggendorfer, M., Hutter, S., Walter, W., Janssen, J., Kern, W., Haferlach, C., Haferlach, T., Jansen, G., Kaspers, G. J. L., Groen, R., Ossenkoppele, G. & Cloos, J., Sept 2021, In: Leukemia. 35, 9, p. 2698-2702 5 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Corrigendum to ‘Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up’: [Annals of Oncology Volume 31, Issue 6, June 2020, Pages 697-712](S0923753420360798)(10.1016/j.annonc.2020.02.018)
ESMO Guidelines Committee, 1 Jun 2021, In: Annals of oncology. 32, 6, p. 821 1 p.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
Inferior outcome of addition of the aminopeptidase inhibitor tosedostat to standard intensive treatment for elderly patients with aml and high risk mds
Janssen, J., Löwenberg, B., Manz, M., Bargetzi, M., Biemond, B., von dem Borne, P., Breems, D., Brouwer, R., Chalandon, Y., Deeren, D., Efthymiou, A., Gjertsen, B.-T., Graux, C., Gregor, M., Heim, D., Hess, U., Hoogendoorn, M., Jaspers, A., Jie, A. & Jongen-Lavrencic, M. & 26 others, , 2 Feb 2021, In: Cancers. 13, 4, p. 1-11 11 p., 672.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
